UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 351

Sortiert nach

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

Blood, 2015-02, Vol.125 (8), p.1333-1338

2015

Volltextzugriff (PDF)

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Blood, 2014-08, Vol.124 (8), p.1372-1377

2014

Volltextzugriff (PDF)

Alternative donor hematopoietic cell transplantation for Fanconi anemia

Blood, 2015-06, Vol.125 (24), p.3798-3804

2015

Volltextzugriff (PDF)

The best endpoint for acute GVHD treatment trials

Blood, 2010-07, Vol.115 (26), p.5412-5417

2010

Volltextzugriff (PDF)

Amphiregulin as a biomarker for monitoring lifethreatening acute graft- versus -host disease: secondary analysis of two prospective clinical trials

Haematologica (Roma), 2024-05, Vol.109 (5), p.1557

2024

Volltextzugriff (PDF)

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Blood, 2009-11, Vol.114 (19), p.4293-4299

2009

Volltextzugriff (PDF)

Validation of Minnesota acute graft- versus -host disease Risk Score

Haematologica (Roma), 2020-02, Vol.105 (2), p.519

2020

Volltextzugriff (PDF)

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

Blood, 2009-03, Vol.113 (11), p.2410-2415

2009

Volltextzugriff (PDF)

Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report

BMC infectious diseases, 2021-09, Vol.21 (1), p.941-941, Article 941

2021

Volltextzugriff (PDF)

Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia

Blood, 2007-03, Vol.109 (5), p.2256-2262

2007

Volltextzugriff (PDF)

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

International journal of molecular sciences, 2022-07, Vol.23 (15), p.8416

2022

Volltextzugriff (PDF)

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1373-1380

2021

Volltextzugriff (PDF)

Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients

Blood, 2011-03, Vol.117 (9), p.2728-2734

2011

Volltextzugriff (PDF)

A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key

Frontiers in pediatrics, 2021-07, Vol.9, p.634449-634449

2021

Volltextzugriff (PDF)

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy

Molecular therapy. Oncolytics, 2023-03, Vol.28, p.197-210

2023

Volltextzugriff (PDF)

Late-Onset Acute and Chronic Graft-versus-Host Disease in Children: Clinical Features and Response to Therapy

Transplantation and cellular therapy, 2021-08, Vol.27 (8), p.667.e1-667.e5

2021

Volltextzugriff (PDF)

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Haematologica (Roma), 2016-06, Vol.101 (6), p.764

2016

Volltextzugriff (PDF)

Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes

Human mutation, 2014-11, Vol.35 (11), p.1342-1353

2014

Volltextzugriff (PDF)

Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-θ restrained suppressive activity

Scientific reports, 2017-06, Vol.7 (1), p.1-8, Article 4258

2017

Volltextzugriff (PDF)

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

Blood, 2016-02, Vol.127 (8), p.1044-1051

2016

Volltextzugriff (PDF)

Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: Analysis of Graft Sources and Long-Term Outcome

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3634-3641

2009

Volltextzugriff (PDF)

Management of Acute Graft-Versus-Host Disease in Children

The Pediatric clinics of North America, 2010-02, Vol.57 (1), p.273-295

2010

Volltextzugriff (PDF)

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Blood, 2007-03, Vol.109 (6), p.2657-2662

2007

Volltextzugriff (PDF)

Formation of cyclophosphamide specific DNA adducts in hematological diseases

Pediatric blood & cancer, 2012-05, Vol.58 (5), p.708-714

2012

Volltextzugriff (PDF)

1 – 25 von 351

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(335)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(152)
Life Sciences & Biomedicine
(151)
Humans
(125)
Hematology
(114)
Male
(89)
Female
(87)
Transplantation
(79)
Adult
(69)
Child
(68)
Adolescent
(65)
Immunology
(60)
Middle Aged
(53)
Child, Preschool
(51)
Hematology, Oncology And Palliative Medicine
(34)
Biological And Medical Sciences
(33)
Hematopoietic Stem Cell Transplantation
(33)
Infant
(33)
Aged
(32)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(31)
Medical Sciences
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT

Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial

Alternative donor hematopoietic cell transplantation for Fanconi anemia

The best endpoint for acute GVHD treatment trials

Amphiregulin as a biomarker for monitoring lifethreatening acute graft- versus -host disease: secondary analysis of two prospective clinical trials

Relapse risk after umbilical cord blood transplantation: enhanced graft-versus-leukemia effect in recipients of 2 units

Validation of Minnesota acute graft- versus -host disease Risk Score

Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors

Detection and treatment of cerebral toxoplasmosis in an aplastic pediatric post-allogeneic hematopoietic cell transplant patient: a case report

Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

Hematopoietic cell transplantation comorbidity index predicts transplantation outcomes in pediatric patients

A Review of Infections After Hematopoietic Cell Transplantation Requiring PICU Care: Transplant Timeline Is Key

Characterization and quantitation of busulfan DNA adducts in the blood of patients receiving busulfan therapy

Late-Onset Acute and Chronic Graft-versus-Host Disease in Children: Clinical Features and Response to Therapy

Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults

Comprehensive Analysis of Pathogenic Deletion Variants in Fanconi Anemia Genes

Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-θ restrained suppressive activity

Umbilical cord blood–derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect

Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia: Analysis of Graft Sources and Long-Term Outcome

Management of Acute Graft-Versus-Host Disease in Children

A phase 2/3 multicenter randomized clinical trial of ABX-CBL versus ATG as secondary therapy for steroid-resistant acute graft-versus-host disease

Formation of cyclophosphamide specific DNA adducts in hematological diseases

Suchergebnisse filtern